Lucilla Parnetti

Active 1992–2025

183
Papers
22,017
Citations
83
h-index
168
i10-index

Citations

Citations per year for Lucilla Parnetti1992: 1 citations1997: 5 citations1998: 5 citations1999: 7 citations2000: 20 citations2001: 19 citations2002: 28 citations2003: 30 citations2004: 51 citations2005: 37 citations2006: 35 citations2007: 52 citations2008: 77 citations2009: 80 citations2010: 90 citations2011: 85 citations2012: 83 citations2013: 101 citations2014: 166 citations2015: 150 citations2016: 176 citations2017: 235 citations2018: 283 citations2019: 832 citations2020: 1,073 citations2021: 1,074 citations2022: 1,081 citations2023: 862 citations2024: 1,430 citations2025: 709 citations2026: 17 citations1993–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,467 citing papers, 18.3% of this breakdownUnited Kingdom: 1,298 citing papers, 9.6% of this breakdownItaly: 1,238 citing papers, 9.2% of this breakdownChina: 904 citing papers, 6.7% of this breakdownSweden: 873 citing papers, 6.5% of this breakdownGermany: 748 citing papers, 5.6% of this breakdownNetherlands: 550 citing papers, 4.1% of this breakdownSpain: 532 citing papers, 4% of this breakdownFrance: 500 citing papers, 3.7% of this breakdownCanada: 422 citing papers, 3.1% of this breakdownAustralia: 343 citing papers, 2.6% of this breakdownSwitzerland: 313 citing papers, 2.3% of this breakdown
0%18.3%Other 24.3%

Fields

  • Medicine69.8%
  • Neuroscience13.4%
  • Biochemistry, Genetics and Molecular Biology10.4%
  • Health Professions1.1%
  • Immunology and Microbiology1%
  • Psychology0.8%
  • Other3.5%

Topics

  • Alzheimer's disease research and treatments12.3%
  • Dementia and Cognitive Impairment Research10.1%
  • Parkinson's Disease Mechanisms and Treatments6.8%
  • Neurological disorders and treatments2.7%
  • Neuroinflammation and Neurodegeneration Mechanisms2.6%
  • Functional Brain Connectivity Studies2.3%
  • Other63.2%

Coauthors

All papers

Open in search
  1. Neurofilament light chain as a biomarker in neurological disorders

    Authors: , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2019 cited by 1,327

  2. Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wiesje M. van der Flier, Lisa Ford, Stefan Förster, Juan Fortea, Nadia Foskett, Kristian Steen Frederiksen, Yvonne Freund‐Levi, Giovanni B. Frisoni, Lutz Froelich, Tomasz Gabryelewicz, Kiran Dip Gill, Olymbia Gkatzima, Estrella Gómez‐Tortosa, Mark Forrest Gordon, Timo Grimmer, Harald Hampel, Lucrezia Hausner, Sabine Hellwig, Sanna‐Kaisa Herukka, Helmut Hildebrandt, Lianna Ishihara, Adrian Ivanoiu, William J. Jagust, Peter Johannsen, Ramesh Kandimalla, Elisabeth Kapaki, Aleksandra Klimkowicz‐Mrowiec, William E. Klunk, Sebastian Köhler, Norman Koglin, Johannes Kornhuber, Milica G. Kramberger, Koen Van Laere, Susan Landau, Dong Young Lee, Mony J. de Leon, Viviana Lisetti, Alberto Lleó, Karine Madsen, Wolfgang Maier, Jan Marcusson, Niklas Mattsson, Alexandre de Mendonça, Olga Meulenbroek, Philipp T. Meyer, Mark A. Mintun, Vincent Mok, José Luís Molinuevo, Hanne M. Møllergård, John C. Morris, Barbara Mroczko, Stefan Van der Mussele, Duk L. Na, Andrew B. Newberg, Agneta Nordberg, Arto Nordlund, Gerald Novak, George P. Paraskevas, Lucilla Parnetti, Gayan Perera, Oliver Peters, Julius Popp, Sudesh Prabhakar, Gil D. Rabinovici, Inez H.G.B. Ramakers, Lorena Rami, Catarina R. Oliveira, Juha O. Rinne, Karen M. Rodrigue, Eloy Rodríguez‐Rodríguez and 29 more - JAMA 2015 cited by 1,635

  3. A multicentre validation study of the diagnostic value of plasma neurofilament light

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , André Strydom, Per Svenningsson, Erik Stomrud, Alexander Santillo, Dag Aarsland, John C. van Swieten, Sebastian Palmqvist, Henrik Zetterberg, Kaj Blennow, Abdul Hye, Oskar Hansson - Nature Communications 2021 cited by 555

  4. CSF and blood biomarkers for Parkinson's disease

    Authors: , , , , , , , , - The Lancet Neurology 2019 cited by 671

  5. α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies

    Authors: , , , , , - Neurology 2022 cited by 154

  6. Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Chemistry and Laboratory Medicine (CCLM) 2021 cited by 150

  7. The Mental Deterioration Battery: Normative Data, Diagnostic Reliability and Qualitative Analyses of Cognitive Impairment

    Authors: , , , , , , , , , - European Neurology 2008 cited by 1,243

  8. Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay

    Authors: , , , , , , , , , , - Alzheimer s & Dementia 2024 cited by 108

  9. A Practical Guide to Immunoassay Method Validation

    Authors: , , , , , , , , , , , , , , , , , , , , - Frontiers in Neurology 2015 cited by 544

  10. Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raquel Sánchez‐Valle, Victoria Álvarez, Merçé Boada, Pablo García‐González, Raquel Puerta, Pablo Mir, Luís Miguel Real, Gerard Piñol‐Ripoll, José María García‐Alberca, José Luís Royo, Eloy Rodríguez‐Rodríguez, Hilkka Soininen, Teemu Kuulasmaa, Alexandre de Mendonça, Shima Mehrabian, Jakub Hort, Martin Vyhnálek, Sven J. van der Lee, Caroline Graff, Goran Papenberg, Vilmantas Giedraitis, Anne Boland, Delphine Bacq‐Daian, Jean‐François Deleuze, Gaël Nicolas, Carole Dufouil, Florence Pasquier, Olivier Hanon, Stéphanie Debette, Edna Grünblatt, Julius Popp, Luisa Benussi, Daniela Galimberti, Beatrice Arosio, Patrizia Mecocci, Vincenzo Solfrizzi, Lucilla Parnetti, Alessio Squassina, Lucio Tremolizzo, Barbara Borroni, Benedetta Nacmias, Sandro Sorbi, Paolo Caffarra, Davide Seripa, Innocenzo Rainero, Antonio Daniele, Carlo Masullo, Gianfranco Spalletta, Julie Williams, Philippe Amouyel, Frank Jessen, Patrick G. Kehoe, Magda Tsolaki, Giacomina Rossi, Pascual Sánchez‐Juan, Kristel Sleegers, Martin Ingelsson, Ole A. Andreassen, Mikko Hiltunen, Cornelia M. van Duijn, Rebecca Sims, Wiesje M. van der Flier, Agustı́n Ruiz, Alfredo Ramı́rez, Jean‐Charles Lambert, Ruth Frikke‐Schmidt - JAMA Network Open 2023 cited by 93

  11. Consensus guidelines for lumbar puncture in patients with neurological diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Erik Stomrud, Hayrettin Tumani, Pieter Jelle Visser, Anders Wallin, Bengt Winblad, Henrik Zetterberg, Flora H. Duits, Charlotte E. Teunissen - Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2017 cited by 356

  12. Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ruth Frikke‐Schmidt, Julie Williams, Agustı́n Ruiz, Jean‐Charles Lambert, Michael D. Greicius, Members of the EADB, GR@ACE, DEGESCO, DemGene, GERAD, and EADI Groups, Beatrice Arosio, Luisa Benussi, Anne Boland, Barbara Borroni, Paolo Caffarra, Delphine Daian, Antonio Daniele, Stéphanie Debette, Carole Dufouil, Emrah Düzel, Daniela Galimberti, Vilmantas Giedraitis, Timo Grimmer, Caroline Graff, Edna Grünblatt, Olivier Hanon, Lucrezia Hausner, Stefanie Heilmann‐Heimbach, Henne Holstege, Jakub Hort, Jürgen Deckert, Teemu Kuulasmaa, Aad van der Lugt, Carlo Masullo, Patrizia Mecocci, Shima Mehrabian, Alexandre de Mendonça, Susanne Moebus, Benedetta Nacmias, Gaël Nicolas, Robert Olaso, Goran Papenberg, Lucilla Parnetti, Florence Pasquier, Oliver Peters, Yolande A.L. Pijnenburg, Julius Popp, Innocenzo Rainero, Inez Ramakers, Steffi G. Riedel‐Heller, Nikolaos Scarmeas, Philip Scheltens, Norbert Scherbaum, Anja Schneider, Davide Seripa, Hilkka Soininen, Vincenzo Solfrizzi, Gianfranco Spalletta, Alessio Squassina, John C. van Swieten, Thomas Tegos, Lucio Tremolizzo, Frans Verhey, Martin Vyhnálek, Jens Wiltfang, Merçé Boada, Pablo García‐González, Raquel Puerta, Luís Miguel Real, Victoria Álvarez, María J. Bullido, Jordi Clarimón, José María García‐Alberca, Pablo Mir and 10 more - JAMA Neurology 2022 cited by 93

  13. Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease

    Authors: , , , , , , - Molecular Neurodegeneration 2017 cited by 278

  14. Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease

    Authors: , , , , , , , , - Journal of Alzheimer s Disease 2016 cited by 259

  15. Diagnostic utility of cerebrospinal fluid α‐synuclein in Parkinson's disease: A systematic review and meta‐analysis

    Authors: , , , , , , , - Movement Disorders 2017 cited by 222

  16. Prevalence and risk of progression of preclinical Alzheimer’s disease stages: a systematic review and meta-analysis

    Authors: , , , , - Alzheimer s Research & Therapy 2019 cited by 184

  17. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative

    Authors: , , , , , , , , , , , - Alzheimer s & Dementia 2011 cited by 368

  18. Effect of a Novel Free Radical Scavenger, Edaravone (MCI-186), on Acute Brain Infarction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ingo-W. Husstedt, Antonio Arauz, Leora Velásquez, Carlos Cantú, Juan Nader, Mario López, Luis Murillo, Yolanda Aburto, Patrizia Nencini, Cristina Sarti, Rinaldo Innocenti, Giovanni Pracucci, Domenico Inzitari, Kyoung Heo, Sun Ah Park, Jong Yun Lee, Byung In Lee, Seung-Koo Lee, Patricia Canhão, José M. Ferro, Dénes Páll, Georgios Settakis, Éva Katona, László Csiba, György Kakuk, Martien Limburg, Dániel Bereczki, Béla Fülesdi, Maurizio Paciaroni, Valeria Caso, Gabriela Cardaioli, Francesco Corea, Paolo Milia, Michele Venti, Mohammed Hamam, Gian Piero Pelliccioli, Lucilla Parnetti, Virgilio Gallai, Thanh G. Phan, John Huston, III - Cerebrovascular Diseases 2003 cited by 664

  19. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gunilla Johansson, Natalia Ermann, John Q. Trojanowski, Ilker Karaca, Holger Wagner, Patrick Oeckl, Linda van Waalwijk van Doorn, Maria Bjerke, Dimitrios Kapogiannis, H. Bea Kuiperij, Lucia Farotti, Yi Li, Brian A. Gordon, Stéphane Epelbaum, Stephanie J. B. Vos, Catharina J.M. Klijn, William E. Van Nostrand, Carolina Minguillón, Matthias Schmitz, Carla Gallo, Andrea Lopez Mato, Florence Thibaut, Simone Lista, Daniel Alcolea, Henrik Zetterberg, Kaj Blennow, Johannes Kornhuber, on Behalf of the Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato, Florence Thibaut - The World Journal of Biological Psychiatry 2017 cited by 318

  20. Amyloid-β: a potential link between epilepsy and cognitive decline

    Authors: , , , , - Nature Reviews Neurology 2021 cited by 133

  21. Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers

    Authors: , , , , , , , - Movement Disorders 2022 cited by 88

  22. Fluid biomarkers in multiple sclerosis: from current to future applications

    Authors: , , , , , , , , , , - The Lancet Regional Health - Europe 2024 cited by 64

  23. Cerebrospinal fluid lysosomal enzymes and alpha‐synuclein in Parkinson's disease

    Authors: , , , , , , , , , , , , , , , , , , , - Movement Disorders 2014 cited by 273

  24. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation

    Authors: , , , , , , , , , , - Alzheimer s Research & Therapy 2018 cited by 190